Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

about

Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation.Lymphotoxin β receptor-mediated NFκB signaling promotes glial lineage differentiation and inhibits neuronal lineage differentiation in mouse brain neural stem/progenitor cells.

P2860

Q40185624-E7915917-019A-4465-89E0-6F6C2B7F139D Q49795149-7E83750F-3F51-4717-AF4C-27B6607415DC

P2860

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

Item

http://www.wikidata.org/entity/Q39245218

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

@en

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

@nl

type

Item

label

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

@en

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

@nl

prefLabel

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

@en

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

@nl

P1476

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy

@en

P2093

Jian Qiao

http://www.w3.org/2001/XMLSchema#string

Mingzhao Zhu

http://www.w3.org/2001/XMLSchema#string

Yang-Xin Fu

http://www.w3.org/2001/XMLSchema#string

P2860

LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator

CCR7 and its ligands: balancing immunity and tolerance

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment

The STING pathway and the T cell-inflamed tumor microenvironment

In vivo depletion of lymphotoxin-alpha expressing lymphocytes inhibits xenogeneic graft-versus-host-disease

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade

Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues

P2888

cmi.2017.13

P304

809-818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CMI.2017.13

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Haidong Tang

P577

2017-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28413217

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5649108

http://www.w3.org/2001/XMLSchema#string

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

about

P2860

P2860

Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932